5 quarters tracked · Beat rate 40% · Updated quarterly
| Period | Report Date | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|---|
| Q4 2026 | 2026-06-30 | $1.45 | $1.43 | -1.5% | Miss |
| Q3 2026 | 2026-03-31 | $1.60 | $1.59 | -0.8% | Miss |
| Q2 2026 | 2025-12-31 | $1.91 | $1.88 | -1.6% | Miss |
| Q1 2026 | 2025-09-30 | $1.95 | $1.99 | +1.9% | Beat |
| Q4 2025 | 2025-06-30 | $1.46 | $1.48 | +1.2% | Beat |
Earnings Beat Rate
Procter & Gamble has beaten analyst EPS estimates in 2 of 5 tracked quarters (40% beat rate). Data sourced from SEC filings and analyst consensus. View full AI analysis →